Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA
dc.contributor.author | Van Rensburg, Ilana C. | en_ZA |
dc.contributor.author | Wagman, Chandre | en_ZA |
dc.contributor.author | Stanley, Kim | en_ZA |
dc.contributor.author | Beltran, Caroline | en_ZA |
dc.contributor.author | Ronacher, Katharina | en_ZA |
dc.contributor.author | Walzl, Gerhard | en_ZA |
dc.contributor.author | Loxton, Andre G. | en_ZA |
dc.date.accessioned | 2016-10-28T06:55:52Z | |
dc.date.available | 2016-10-28T06:55:52Z | |
dc.date.issued | 2016-09 | |
dc.description | CITATION: Van Rensburg, I. C., et al. 2016. Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA. Oncotarget, doi:10.18632/oncotarget.12184 | |
dc.description | The original publication is available at http://www.impactjournals.com/oncotarget | |
dc.description | Publication of this article was funded by the Stellenbosch University Open Access Fund. | |
dc.description.abstract | ENGLISH ABSTRACT: Activated B-cells increase T-cell behaviour during autoimmune disease and other infections by means of cytokine production and antigen-presentation. Functional studies in experimental autoimmune encephalomyelitis (EAE) indicate that B-cell deficiencies, and a lack of IL10 and IL35 leads to a poor prognosis. We hypothesised that B-cells play a role during tuberculosis. We evaluated B-cell mRNA expression using real-time PCR from healthy community controls, individuals with other lung diseases and newly diagnosed untreated pulmonary TB patients at three different time points (diagnosis, month 2 and 6 of treatment). We show that FASLG, IL5RA, CD38 and IL4 expression was lower in B-cells from TB cases compared to healthy controls. The changes in expression levels of CD38 may be due to a reduced activation of B-cells from TB cases at diagnosis. By month 2 of treatment, there was a significant increase in the expression of APRIL and IL5RA in TB cases. Furthermore, after 6 months of treatment, APRIL, FASLG, IL5RA and CD19 were upregulated in B-cells from TB cases. The increase in the expression of APRIL and CD19 suggests that there may be restored activation of B-cells following anti-TB treatment. The upregulation of FASLG and IL5RA indicates that B-cells expressing regulatory genes may play an important role in the protective immunity against M.tb infection. Our results show that increased activation of B-cells is present following successful TB treatment, and that the expression of FASLG and IL5RA could potentially be utilised as a signature to monitor treatment response. | en_ZA |
dc.description.uri | http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=12184&path%5B%5D=38572 | |
dc.description.version | Publisher's version | |
dc.format.extent | 8 pages : illustrations | en_ZA |
dc.identifier.citation | Van Rensburg, I. C., et al. 2016. Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA. Oncotarget, doi:10.18632/oncotarget.12184 | |
dc.identifier.issn | 1949-2553 (online) | |
dc.identifier.other | doi:10.18632/oncotarget.12184 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/99777 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Impact Journals | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Lungs -- Tuberculosis -- Treatment | en_ZA |
dc.subject | Messenger RNA | en_ZA |
dc.subject | Autoimmune diseases | en_ZA |
dc.subject | B cells | en_ZA |
dc.title | Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA | en_ZA |
dc.type | Article | en_ZA |